Myeloid cell-specific Beta2-adrenergic receptor deletion improves early cardiac injury resolution via de-repression of Anxa1
Related Posts
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation
Oshima A, Serruys PW, Garg S, McEvoy JW, Wood DA, Doenst T, Taggart DP, Puskas JD, Shajahan A, Sharif F, Miyashita K, Tobe A, Tsai[...]
Nikitas J, Smith CP, Armstrong WR, Murthy V, Grogan T, Clark K, Moore J, Roberts M, Farolfi A, Reiter RE, Rettig MB, Shen J, Valle[...]
Chen G, Kim WJ, Yang Y, Li YR, Tian J, Zhang J, Zhao X, Scott K, Defelice LG, Liu Z, Xu J, Chung T, Carol[...]